{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:19:11Z","timestamp":1790356751549,"version":"4.1.0"},"reference-count":67,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.3201\/eid0302.970208","type":"journal-article","created":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T21:57:18Z","timestamp":1250891838000},"page":"155-163","source":"Crossref","is-referenced-by-count":58,"title":["Is Creutzfeldt-Jakob Disease Transmitted in Blood?"],"prefix":"10.3201","volume":"3","member":"1822","reference":[{"key":"key-10.3201\/eid0302.970208-202410151137-R1","doi-asserted-by":"crossref","unstructured":"1. Masters CL, Harris JO, Gajdusek C, Gibbs CJ, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979;5:177\u201388. PubMeddoi:10.1002\/ana.41005021210.1002\/ana.410050212371520","DOI":"10.1002\/ana.410050212"},{"key":"key-10.3201\/eid0302.970208-202410151137-R2","doi-asserted-by":"crossref","unstructured":"2. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15 year investigation in France and review of the world literature. Neurology. 1987;37:895\u2013904. PubMed3295589","DOI":"10.1212\/WNL.37.6.895"},{"key":"key-10.3201\/eid0302.970208-202410151137-R3","doi-asserted-by":"crossref","unstructured":"3. Will RG. Incidence of Creutzfeldt-Jakob disease in the European Community. In: Gibbs CJ Jr, editor. Bovine Spongiform Encephalopathy: The BSE Dilemma. New York: Springer-Verlag 1996:364-74.","DOI":"10.1007\/978-1-4612-2406-8_27"},{"key":"key-10.3201\/eid0302.970208-202410151137-R4","unstructured":"4. World Health Organization consultation on clinical and neuropathological characteristics of the new variant of CJD and other human and animal TSEs. Geneva: WHO, 1996."},{"key":"key-10.3201\/eid0302.970208-202410151137-R5","unstructured":"5. Creutzfeldt-Jakob disease in Australia: first annual report. Melbourne: The National CJD Registry, 1996."},{"key":"key-10.3201\/eid0302.970208-202410151137-R6","unstructured":"6. Stratton E, Ricketts MN, Gully PR. Creutzfeldt-Jakob disease in Canada. CCDR. 1996;22:57\u201361."},{"key":"key-10.3201\/eid0302.970208-202410151137-R7","doi-asserted-by":"crossref","unstructured":"7. Kovanen J, Haltia M. Descriptive epidemiology of Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand. 1980;77:474\u201380. doi:10.1111\/j.1600-0404.1988.tb05943.x10.1111\/j.1600-0404.1988.tb05943.x","DOI":"10.1111\/j.1600-0404.1988.tb05943.x"},{"key":"key-10.3201\/eid0302.970208-202410151137-R8","doi-asserted-by":"crossref","unstructured":"8. Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB. Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology. 1995;14:174\u201381. PubMeddoi:10.1159\/00010979310.1159\/0001097937643951","DOI":"10.1159\/000109793"},{"key":"key-10.3201\/eid0302.970208-202410151137-R9","doi-asserted-by":"crossref","unstructured":"9. de Silva R. Human spongiform encephalopathy: clinical presentation and diagnostic tests. In: Baker H, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totawa (NJ): Humana Press Inc; 1996:15-33.","DOI":"10.1385\/0-89603-342-2:15"},{"key":"key-10.3201\/eid0302.970208-202410151137-R10","doi-asserted-by":"crossref","unstructured":"10. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:913\u201320. PubMed8815857","DOI":"10.1001\/archneur.1996.00550090125018"},{"key":"key-10.3201\/eid0302.970208-202410151137-R11","doi-asserted-by":"crossref","unstructured":"11. Ironside JW. Neuropathological diagnosis of human prion disease. In: Baker H, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totawa (NJ): Humana Press Inc; 1996:35-57.","DOI":"10.1385\/0-89603-342-2:35"},{"key":"key-10.3201\/eid0302.970208-202410151137-R12","doi-asserted-by":"crossref","unstructured":"12. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39:767\u201378. PubMeddoi:10.1002\/ana.41039061310.1002\/ana.4103906138651649","DOI":"10.1002\/ana.410390613"},{"key":"key-10.3201\/eid0302.970208-202410151137-R13","doi-asserted-by":"crossref","unstructured":"13. Collinge J, Sidle DC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of \"new variant\" CJD. Nature. 1996;383:685\u201390. PubMeddoi:10.1038\/383685a010.1038\/383685a08878476","DOI":"10.1038\/383685a0"},{"key":"key-10.3201\/eid0302.970208-202410151137-R14","doi-asserted-by":"crossref","unstructured":"14. Zerr I, Bodemer M, Otto M, Poser S, Wind IO, Kretzschmar HA, et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet. 1996;348:846\u20139. PubMeddoi:10.1016\/S0140-6736(96)08077-410.1016\/S0140-6736(96)08077-48826809","DOI":"10.1016\/S0140-6736(96)08077-4"},{"key":"key-10.3201\/eid0302.970208-202410151137-R15","doi-asserted-by":"crossref","unstructured":"15. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335:924\u201330. PubMeddoi:10.1056\/NEJM19960926335130310.1056\/NEJM1996092633513038782499","DOI":"10.1056\/NEJM199609263351303"},{"key":"key-10.3201\/eid0302.970208-202410151137-R16","doi-asserted-by":"crossref","unstructured":"16. Manuelidis L. The dimensions of Creutzfeldt-Jakob disease. Transfusion. 1994;34:915\u201328. PubMeddoi:10.1046\/j.1537-2995.1994.341095026981.x10.1046\/j.1537-2995.1994.341095026981.x7940667","DOI":"10.1046\/j.1537-2995.1994.341095026981.x"},{"key":"key-10.3201\/eid0302.970208-202410151137-R17","doi-asserted-by":"crossref","unstructured":"17. Ozel M, Diringer H. Small virus-like structure in fractions from scrapie hamster brain. Lancet. 1994;343:894\u20135. PubMeddoi:10.1016\/S0140-6736(94)90010-810.1016\/S0140-6736(94)90010-87908360","DOI":"10.1016\/S0140-6736(94)90010-8"},{"key":"key-10.3201\/eid0302.970208-202410151137-R18","doi-asserted-by":"crossref","unstructured":"18. Brown P, Preece MA, Will RG. \"Friendly Fire\" in medicine: hormones, homografts and CJD. Lancet. 1992;340:24\u20137. PubMeddoi:10.1016\/0140-6736(92)92431-E10.1016\/0140-6736(92)92431-E1351607","DOI":"10.1016\/0140-6736(92)92431-E"},{"key":"key-10.3201\/eid0302.970208-202410151137-R19","doi-asserted-by":"crossref","unstructured":"19. Lasm\u00e9zas CI, Deslys JP, Robain O, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science. 1997;275:402\u20135. PubMeddoi:10.1126\/science.275.5298.40210.1126\/science.275.5298.4028994041","DOI":"10.1126\/science.275.5298.402"},{"key":"key-10.3201\/eid0302.970208-202410151137-R20","doi-asserted-by":"crossref","unstructured":"20. Collinge J, Palmer MS, Dryden AJ. Genetic pre-disposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991;337:1441\u20132. PubMeddoi:10.1016\/0140-6736(91)93128-V10.1016\/0140-6736(91)93128-V1675319","DOI":"10.1016\/0140-6736(91)93128-V"},{"key":"key-10.3201\/eid0302.970208-202410151137-R21","doi-asserted-by":"crossref","unstructured":"21. Brown P, Gajdusek DC. The Human Spongiform Encephalopathies: Kuru, Creutzfeldt-Jakob Disease, and the Gerstmann-Straussler-Scheinker Syndrome. In: Chesebro BW, editor. Current topics in microbiology and immunology, vol 172. New York: Springer-Verlag, 1991:1-20.","DOI":"10.1007\/978-3-642-76540-7_1"},{"key":"key-10.3201\/eid0302.970208-202410151137-R22","doi-asserted-by":"crossref","unstructured":"22. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921\u20135. PubMeddoi:10.1016\/S0140-6736(96)91412-910.1016\/S0140-6736(96)91412-98598754","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"key-10.3201\/eid0302.970208-202410151137-R23","doi-asserted-by":"crossref","unstructured":"23. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature. 1966;209:794\u20136. PubMeddoi:10.1038\/209794a010.1038\/209794a05922150","DOI":"10.1038\/209794a0"},{"key":"key-10.3201\/eid0302.970208-202410151137-R24","doi-asserted-by":"crossref","unstructured":"24. Gibbs CJ Jr, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM, et al. Creutzfeldt-Jakob disease (subacute spongiform encephalopathy): transmission to the chimpanzee. Science. 1968;161:388\u20139. PubMeddoi:10.1126\/science.161.3839.38810.1126\/science.161.3839.3885661299","DOI":"10.1126\/science.161.3839.388"},{"key":"key-10.3201\/eid0302.970208-202410151137-R25","doi-asserted-by":"crossref","unstructured":"25. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible person-person transmission of CJD. N Engl J Med. 1974;290:692. PubMed4591849","DOI":"10.1056\/NEJM197403212901220"},{"key":"key-10.3201\/eid0302.970208-202410151137-R26","doi-asserted-by":"crossref","unstructured":"26. Liberski PP, Yanagihara R, Gibbs CJ, Gajdusek DC. Spread of Creutzfeldt-Jakob disease virus along visual pathways after intra ocular inoculation. Arch Virol. 1990;111:141\u20137. PubMeddoi:10.1007\/BF0131051210.1007\/BF013105122183743","DOI":"10.1007\/BF01310512"},{"key":"key-10.3201\/eid0302.970208-202410151137-R27","doi-asserted-by":"crossref","unstructured":"27. Maneulidis EE, Maneulidis L. Experiments on maternal transmission of Creutzfeldt-Jakob disease in guinea pigs. Proc Soc Exp Biol Med. 1979;160:233\u20136. PubMed368815","DOI":"10.3181\/00379727-160-40425"},{"key":"key-10.3201\/eid0302.970208-202410151137-R28","doi-asserted-by":"crossref","unstructured":"28. Brown P. Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totawa (NJ): Humana Press Inc; 1996:139-54.","DOI":"10.1385\/0-89603-342-2:139"},{"key":"key-10.3201\/eid0302.970208-202410151137-R29","doi-asserted-by":"crossref","unstructured":"29. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. Danger of accidental person-to-person transmission of CJD by surgery. Lancet. 1977;1:478\u20139. PubMeddoi:10.1016\/S0140-6736(77)91958-410.1016\/S0140-6736(77)91958-465575","DOI":"10.1016\/S0140-6736(77)91958-4"},{"key":"key-10.3201\/eid0302.970208-202410151137-R30","unstructured":"30. Brown P. Transmissible human spongiform encepha-lopathy (infectious cerebral amyloidosis): Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker's syndrome and kuru. In: Calne DB, editor. Neurode-generative diseases. Philadelphia: 1994:839-76."},{"key":"key-10.3201\/eid0302.970208-202410151137-R31","unstructured":"31. Foncin J, Gaches J, Cathala F, El Sharif E, Le Beau J. Transmission iatrogene interhumaine possible de maladie de Creutzfeldt-Jakob disease avec atteinte des grains du cervelet. Rev Neurol. 1980;136:280."},{"key":"key-10.3201\/eid0302.970208-202410151137-R32","doi-asserted-by":"crossref","unstructured":"32. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1982;45:235\u20138. PubMeddoi:10.1136\/jnnp.45.3.23510.1136\/jnnp.45.3.2357045290","DOI":"10.1136\/jnnp.45.3.235"},{"key":"key-10.3201\/eid0302.970208-202410151137-R33","doi-asserted-by":"crossref","unstructured":"33. Nevin S, McMenemy WH, Berhman D, Jones DP. Subacute spongiform encephalopathy: a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain. 1960;83:519\u201364. PubMeddoi:10.1093\/brain\/83.4.51910.1093\/brain\/83.4.51913728615","DOI":"10.1093\/brain\/83.4.519"},{"key":"key-10.3201\/eid0302.970208-202410151137-R34","unstructured":"34. Prichard J, Thadani V, Kalb R, Manuelidis E, Holder J. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Moral Wkly Rep 1987;36:49-50, 55."},{"key":"key-10.3201\/eid0302.970208-202410151137-R35","unstructured":"35. Centers for Disease Control. Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR Morb Moral Wkly Rep 1989;38:37-8, 43."},{"key":"key-10.3201\/eid0302.970208-202410151137-R36","doi-asserted-by":"crossref","unstructured":"36. Esmonde T, Lueck CJD, Symon L, Duchen LW, Will RG. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry. 1994;56:999\u20131000. doi:10.1136\/jnnp.56.9.99910.1136\/jnnp.56.9.999","DOI":"10.1136\/jnnp.56.9.999"},{"key":"key-10.3201\/eid0302.970208-202410151137-R37","unstructured":"37. Centers for Disease Control. Fatal degenerative neurologic disease in patients who received pituitary derived human growth hormone. MMWR Morb Moral Wkly Rep 1985;34:359-60, 365-6."},{"key":"key-10.3201\/eid0302.970208-202410151137-R38","doi-asserted-by":"crossref","unstructured":"38. Cochius JJ, Hyman N, Esiri MM. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotropin, a second case. J Neurol Neurosurg Psychiatry. 1992;55:1094\u20135. PubMeddoi:10.1136\/jnnp.55.11.109410.1136\/jnnp.55.11.10941469410","DOI":"10.1136\/jnnp.55.11.1094"},{"key":"key-10.3201\/eid0302.970208-202410151137-R39","doi-asserted-by":"crossref","unstructured":"39. Brown P, Cervenakova L, Goldfarb LG, McCombie WR, Rubenstein R, Will RG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology. 1994;44:291\u20133. PubMed8309577","DOI":"10.1212\/WNL.44.2.291"},{"key":"key-10.3201\/eid0302.970208-202410151137-R40","doi-asserted-by":"crossref","unstructured":"40. Manuelidis EE, Kim JH, Mericangas JR, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet. 1985;2:896\u20137. PubMeddoi:10.1016\/S0140-6736(85)90165-510.1016\/S0140-6736(85)90165-52864612","DOI":"10.1016\/S0140-6736(85)90165-5"},{"key":"key-10.3201\/eid0302.970208-202410151137-R41","doi-asserted-by":"crossref","unstructured":"41. Tateishi J. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet. 1985;2:1074. PubMeddoi:10.1016\/S0140-6736(85)90949-310.1016\/S0140-6736(85)90949-32865558","DOI":"10.1016\/S0140-6736(85)90949-3"},{"key":"key-10.3201\/eid0302.970208-202410151137-R42","doi-asserted-by":"crossref","unstructured":"42. Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the NIH series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;44:513\u20135. doi:10.1002\/ana.41035050410.1002\/ana.410350504","DOI":"10.1002\/ana.410350504"},{"key":"key-10.3201\/eid0302.970208-202410151137-R43","doi-asserted-by":"crossref","unstructured":"43. Lavelle GC, Sturman L, Hadlow WJ. Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus. Infect Immun. 1972;5:319\u201323. PubMed4629076","DOI":"10.1128\/iai.5.3.319-323.1972"},{"key":"key-10.3201\/eid0302.970208-202410151137-R44","doi-asserted-by":"crossref","unstructured":"44. Kuroda Y, Gibbs CJ, Amyx HL, Gajdusek DC. Creutzfeldt-Jakob disease in mice: persistent viraemia and preferential replication of virus in low density lymphocytes. Infect Immun. 1983;41:154\u201361. PubMed6407995","DOI":"10.1128\/iai.41.1.154-161.1983"},{"key":"key-10.3201\/eid0302.970208-202410151137-R45","doi-asserted-by":"crossref","unstructured":"45. Czub M, Braig HR, Blode H, Diringer H. The major protein of SAF is absent from spleen and thus not an essential part of the scrapie agent. Arch Virol. 1986;91:83\u20136. PubMeddoi:10.1007\/BF0131429710.1007\/BF013142973489451","DOI":"10.1007\/BF01314297"},{"key":"key-10.3201\/eid0302.970208-202410151137-R46","doi-asserted-by":"crossref","unstructured":"46. Manuelidis EE, Gorgacs EJ, Manuelidis L. Viraemia in experimental Creutzfeldt-Jakob disease. Science. 1978;200:1069\u201371. PubMeddoi:10.1126\/science.34969110.1126\/science.349691349691","DOI":"10.1126\/science.349691"},{"key":"key-10.3201\/eid0302.970208-202410151137-R47","doi-asserted-by":"crossref","unstructured":"47. Deslys JP, Lasmezas C, Dormont D. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease [letter]. Lancet. 1994;343:848\u20139. PubMeddoi:10.1016\/S0140-6736(94)92046-X10.1016\/S0140-6736(94)92046-X7908088","DOI":"10.1016\/S0140-6736(94)92046-X"},{"key":"key-10.3201\/eid0302.970208-202410151137-R48","doi-asserted-by":"crossref","unstructured":"48. Matthews WB. Transmission of Creutzfeldt-Jakob disease [letter]. Lancet. 1994;343:1575\u20136. PubMeddoi:10.1016\/S0140-6736(94)92979-310.1016\/S0140-6736(94)92979-37911902","DOI":"10.1016\/S0140-6736(94)92979-3"},{"key":"key-10.3201\/eid0302.970208-202410151137-R49","doi-asserted-by":"crossref","unstructured":"49. Creange A, Gray F, Cesaro, Adle-Biassette H, Duvoux C, Cherqui D, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol. 1995;38:269\u201372. PubMeddoi:10.1002\/ana.41038022310.1002\/ana.4103802237654078","DOI":"10.1002\/ana.410380223"},{"key":"key-10.3201\/eid0302.970208-202410151137-R50","doi-asserted-by":"crossref","unstructured":"50. Klein R, Dumble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet. 1993;341:768. PubMeddoi:10.1016\/0140-6736(93)90549-V10.1016\/0140-6736(93)90549-V8095678","DOI":"10.1016\/0140-6736(93)90549-V"},{"key":"key-10.3201\/eid0302.970208-202410151137-R51","doi-asserted-by":"crossref","unstructured":"51. Collins S, Masters CL. Iatrogenic and zoonotic Creutzfeldt-Jakob disease: the Australian perspective. Med J Aust. 1996;164:598\u2013602. PubMed8637463","DOI":"10.5694\/j.1326-5377.1996.tb122202.x"},{"key":"key-10.3201\/eid0302.970208-202410151137-R52","doi-asserted-by":"crossref","unstructured":"52. Will RG. Surveillance of prion diseases in humans. In: Baker H, Ridley RM, editors. Methods in molecular medicine: prion diseases. Totawa (NJ): Humana Press Inc., 1996;119-37.","DOI":"10.1385\/0-89603-342-2:119"},{"key":"key-10.3201\/eid0302.970208-202410151137-R53","unstructured":"53. Reingold A, Rothrock G, Starr M, Reilly K, Vugia D, Waterman S, et al. Surveillance for Creutzfeldt-Jakob disease-United States. MMWR Morb Mortal Wkly Rep. 1996;45:665\u20138. PubMed8769655"},{"key":"key-10.3201\/eid0302.970208-202410151137-R54","doi-asserted-by":"crossref","unstructured":"54. Raubertas RF, Brown P, Cathala F, Brown I. The Question of clustering of Creutzfeldt-Jakob disease. Am J Epidemiol. 1989;129:146\u201354. PubMed2642649","DOI":"10.1093\/oxfordjournals.aje.a115103"},{"key":"key-10.3201\/eid0302.970208-202410151137-R55","doi-asserted-by":"crossref","unstructured":"55. Kondo K, Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol. 1982;11:377\u201381. PubMeddoi:10.1002\/ana.41011041010.1002\/ana.4101104107049055","DOI":"10.1002\/ana.410110410"},{"key":"key-10.3201\/eid0302.970208-202410151137-R56","doi-asserted-by":"crossref","unstructured":"56. Will RG. Epidemiological surveillance of Creutzfeldt-Jakob disease in the United Kingdom. Eur J Epidemiol. 1991;7:460\u20135. PubMeddoi:10.1007\/BF0014312210.1007\/BF001431221761103","DOI":"10.1007\/BF00143122"},{"key":"key-10.3201\/eid0302.970208-202410151137-R57","doi-asserted-by":"crossref","unstructured":"57. Esmonde TFG, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet. 1993;341:205\u20137. PubMeddoi:10.1016\/0140-6736(93)90068-R10.1016\/0140-6736(93)90068-R8093499","DOI":"10.1016\/0140-6736(93)90068-R"},{"key":"key-10.3201\/eid0302.970208-202410151137-R58","doi-asserted-by":"crossref","unstructured":"58. Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. 1988;51:1113\u20139. PubMeddoi:10.1136\/jnnp.51.9.111310.1136\/jnnp.51.9.11133066847","DOI":"10.1136\/jnnp.51.9.1113"},{"key":"key-10.3201\/eid0302.970208-202410151137-R59","unstructured":"59. Esmonde TFG, Ireland BN, Will RG, Ironside J. Creutzfeldt-Jakob disease: A case-control study. [Abstract 260P]. Neurology. 1994;44:A193."},{"key":"key-10.3201\/eid0302.970208-202410151137-R60","doi-asserted-by":"crossref","unstructured":"60. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology. 1985;35:1483\u20136. PubMed3897896","DOI":"10.1212\/WNL.35.10.1483"},{"key":"key-10.3201\/eid0302.970208-202410151137-R61","doi-asserted-by":"crossref","unstructured":"61. Walter SD. Determination of significant relative risks and optimal sampling procedures in prospective and retrospective comparative studies of various sizes. Am J Epidemiol. 1977;105:387\u201397. PubMed848486","DOI":"10.1093\/oxfordjournals.aje.a112395"},{"key":"key-10.3201\/eid0302.970208-202410151137-R62","doi-asserted-by":"crossref","unstructured":"62. Wientjens DPWM, Davinipour Z, Hofman A, Kondo K, Matthews WB, Will RG, et al. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology. 1996;46:1287\u201391. PubMed8628468","DOI":"10.1212\/WNL.46.5.1287"},{"key":"key-10.3201\/eid0302.970208-202410151137-R63","doi-asserted-by":"crossref","unstructured":"63. Operskalski EA, Mosley JW. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet. 1995;346:1223. doi:10.1016\/S0140-6736(95)92925-810.1016\/S0140-6736(95)92925-8","DOI":"10.1016\/S0140-6736(95)92925-8"},{"key":"key-10.3201\/eid0302.970208-202410151137-R64","unstructured":"64. Schlesselman JJ, Stolley PD. Sources of bias. In: Schlesselman JJ, editor. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982:124-43."},{"key":"key-10.3201\/eid0302.970208-202410151137-R65","doi-asserted-by":"crossref","unstructured":"65. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet. 1994;343:298\u20139. PubMeddoi:10.1016\/S0140-6736(94)91148-710.1016\/S0140-6736(94)91148-77905126","DOI":"10.1016\/S0140-6736(94)91148-7"},{"key":"key-10.3201\/eid0302.970208-202410151137-R66","doi-asserted-by":"crossref","unstructured":"66. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol. 1995;2:472\u20137. PubMed9372038","DOI":"10.1097\/00062752-199502060-00012"},{"key":"key-10.3201\/eid0302.970208-202410151137-R67","doi-asserted-by":"crossref","unstructured":"67. Deslys JP, Lasmezas CI, Billette de Villemeur T, Jaegly A, Dormont D. Creutzfeldt-Jakob disease. Lancet. 1996;347:1332. PubMeddoi:10.1016\/S0140-6736(96)90979-410.1016\/S0140-6736(96)90979-48622524","DOI":"10.1016\/S0140-6736(96)90979-4"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/3\/2\/97-0208_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T01:19:59Z","timestamp":1732583999000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/3\/2\/97-0208_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid0302.970208","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}